Public access defibrillation: challenges and new solutions

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 2,12 MB, PDF-dokument

Purpose of review
The purpose of this article is to review the current status of public access defibrillation and the various utility modalities of early defibrillation.

Recent findings
Defibrillation with on-site automated external defibrillators (AEDs) has been the conventional approach for public access defibrillation. This strategy is highly effective in cardiac arrests occurring in close proximity to on-site AEDs; however, only a few cardiac arrests will be covered by this strategy. During the last decades, additional strategies for public access defibrillation have developed, including volunteer responder programmes and drone assisted AED-delivery. These programs have increased chances of early defibrillation within a greater radius, which remains an important factor for survival after out-of-hospital cardiac arrest.

Summary
Recent advances in the use of public access defibrillation show great potential for optimizing early defibrillation. With new technological solutions, AEDs can be transported to the cardiac arrest location reaching OHCAs in both public and private locations. Furthermore, new technological innovations could potentially identify and automatically alert the emergency medical services in nonwitnessed OHCA previously left untreated.
OriginalsprogEngelsk
TidsskriftCurrent Opinion in Critical Care
Vol/bind29
Udgave nummer3
Sider (fra-til)168-174
Antal sider7
ISSN1070-5295
DOI
StatusUdgivet - 2023

Bibliografisk note

Funding Information:
All authors have received fundings from TrygFonden. Copenhagen EMS has received an unrestricted research grant from the Laerdal Foundation. Dr Folke has received a research grant from the Novo Nordisk Fonden NNF19OC0055142.

Funding Information:
All authors have received fundings from TrygFonden. Copenhagen EMS has received an unrestricted research grant from the Laerdal Foundation. Dr Folke has received a research grant from the Novo Nordisk Fonden NNF19OC0055142.

Publisher Copyright:
Copyright © 2023 The Author(s).

ID: 363675004